• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Amplitude Healthcare Acquisition Corporation

    10/4/21 4:34:30 PM ET
    $AMHC
    Business Services
    Finance
    Get the next $AMHC alert in real time by email
    SC 13G 1 ea148368-13gampli_jasper.htm SCHEDULE 13G

     

     

      UNITED STATES  
      SECURITIES AND EXCHANGE COMMISSION  
      Washington, D.C. 20549  

     

    SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934
    (Amendment No. )*

     

    JASPER THERAPEUTICS, INC.

    (Name of Issuer)

     

    Common Stock, par value $0.0001

    (Title of Class of Securities)

     

    471871 103

    (CUSIP Number)

     

    September 24, 2020

    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ☐ Rule 13d-1(b)
    ☒ Rule 13d-1(c)
    ☐ Rule 13d-1(d)

     

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

     

      1. Names of Reporting Persons
    Amplitude Healthcare Holdings LLC
     
      2. Check the Appropriate Box if a Member of a Group (See Instructions)
        (a) ☐
        (b) ☒
     
      3.

    SEC Use Only

         

     
      4. Citizenship or Place of Organization
    Delaware

         
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    5. Sole Voting Power
    2,300,000(1)
     
    6. Shared Voting Power
    0 
     
    7. Sole Dispositive Power
    2,300,000(1)
       
    8.

    Shared Dispositive Power

       

     

      9. Aggregate Amount Beneficially Owned by Each Reporting Person
    2,300,000(1)
     
      10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  ☐
     
      11. Percent of Class Represented by Amount in Row (9)
    6.30%(2)
     
      12. Type of Reporting Person (See Instructions)
    OO

     

    2

     

     

      1. Names of Reporting Persons
    Metalmark Amplitude Healthcare Holdings LLC
     
      2. Check the Appropriate Box if a Member of a Group (See Instructions)
        (a) ☐
        (b) ☒
     
      3. SEC Use Only
     
      4. Citizenship or Place of Organization
    Delaware

     

    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    5. Sole Voting Power

    0

     
    6. Shared Voting Power
     2,300,000(1)
     
    7. Sole Dispositive Power

     0

     
    8.

    Shared Dispositive Power

    2,300,000(1)   

     

      9. Aggregate Amount Beneficially Owned by Each Reporting Person
    2,300,000(1)
     
      10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  ☐
     
      11. Percent of Class Represented by Amount in Row (9)
    6.30%(2)
     
      12. Type of Reporting Person (See Instructions)
    OO

     

    3

     

     

      1. Names of Reporting Persons
    HC IC HOLDINGS LLC
     
      2. Check the Appropriate Box if a Member of a Group (See Instructions)
        (a) ☐
        (b) ☒
     
      3.

    SEC Use Only

       

     
      4. Citizenship or Place of Organization
    Delaware

         
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    5. Sole Voting Power
    200,000(3)
     
    6. Shared Voting Power
     
     
    7. Sole Dispositive Power
    200,000(3)
     
    8.

    Shared Dispositive Power

       

     
      9. Aggregate Amount Beneficially Owned by Each Reporting Person
    200,000(3)
     
      10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  ☐
     
      11. Percent of Class Represented by Amount in Row (9)
    0.55%(2)
     
      12. Type of Reporting Person (See Instructions)
    OO

     

    4

     

     

      1. Names of Reporting Persons
    Howard I. Hoffen

      

      2. Check the Appropriate Box if a Member of a Group (See Instructions)
        (a) ☐
        (b) ☒
     
      3. SEC Use Only
     
      4. Citizenship or Place of Organization
    Delaware

         
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    5. Sole Voting Power
    0
     
    6. Shared Voting Power
    2,500,000(1)(3)
     
    7. Sole Dispositive Power
     0
     
    8. Shared Dispositive Power
    2,500,000(1)(3)

     
      9. Aggregate Amount Beneficially Owned by Each Reporting Person
    2,500,000(1)(3)
     
      10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ☐
     
      11. Percent of Class Represented by Amount in Row (9)
    6.85%(2)
     
      12. Type of Reporting Person (See Instructions)
    IN

     

    5

     

     

      1. Names of Reporting Persons
    Kenneth F. Clifford
     
      2. Check the Appropriate Box if a Member of a Group (See Instructions)
        (a) ☐
        (b) ☒
     
      3. SEC Use Only
     
      4. Citizenship or Place of Organization
    Delaware

         
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    5. Sole Voting Power
    0
     
    6. Shared Voting Power
    2,500,000(1)(3)
     
    7. Sole Dispositive Power
    0
     
    8. Shared Dispositive Power
    2,500,000(1)(3)

     
      9. Aggregate Amount Beneficially Owned by Each Reporting Person
    2,500,000(1)(3)
     
      10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  ☐
     
      11. Percent of Class Represented by Amount in Row (9)
    6.85%(2)
     
      12. Type of Reporting Person (See Instructions)
    IN

     

    (1) Amplitude Healthcare Holdings LLC, is the record holder of the shares reported herein. Metalmark Amplitude Healthcare Holdings LLC is the managing member of Amplitude Healthcare Holdings LLC. Mr. Hoffen and Mr. Clifford, as partners of Metalmark Capital II LLC (“Metalmark”), which is the managing member of Metalmark Amplitude Healthcare Holdings LLC. Mr. Hoffen and Mr. Clifford may be deemed to share beneficial ownership of the shares directly held by Amplitude Healthcare Holdings LLC. Each such person disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest they may have therein.

    (2) Percentage based on 36,520,288 shares of the Issuer’s Voting Common Stock outstanding as of September 24, 2021, as reported in the Issuer’s Current Report on Form 8-K filed with the Securities and Exchange Commission on September 29, 2021.

    (3) HC IC Holdings LLC is the record holder of the shares reported herein. Mr. Hoffen and Mr. Clifford are the members of HC IC Holdings LLC. Mr. Hoffen and Mr. Clifford may be deemed to share beneficial ownership of the shares directly held by HC IC Holdings LLC. Each such person disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest they may have therein.

     

    6

     

     

    Item 1.
      (a)

    Name of Issuer
    Jasper Therapeutics, Inc. (the “Issuer”)

     

      (b)

    Address of Issuer’s Principal Executive Offices
    2200 Bridge Parkway, Suite #102

    Redwood City, CA 94065

     
    Item 2.
      (a)

    Name of Person Filing
    Amplitude Healthcare Holdings LLC, Metalmark Amplitude Healthcare Holdings LLC, HC IC Holdings LLC, Howard Hoffen, Kenneth Clifford (collectively, the “Reporting Persons”)


      (b)

    Address of Principal Business Office or, if none, Residence
    1177 Avenue of the Americas, Fl 40

    New York, NY 10036

     

      (c)

    Citizenship
    Amplitude Healthcare Holdings LLC is a limited liability company formed in Delaware. Metalmark Amplitude Healthcare Holdings LLC is a limited liability company formed in Delaware. HC IC Holdings LLC is a limited liability company formed in Delaware. Each of Howard Hoffen and Kenneth Clifford is a citizen of the United States of America.

     

      (d)

    Title of Class of Securities
    Voting Common Stock, par value $0.0001

     

      (e)

    CUSIP Number
    471871 103

     

     
    Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
       
      (a) ☐ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
           
      (b) ☐ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
           
      (c) ☐ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
           
      (d) ☐ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
           
      (e) ☐ An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
           
      (f) ☐ An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
           
      (g) ☐ A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
           
      (h) ☐ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
           
      (i) ☐ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
           
      (j) ☐ A non-U.S. institution in accordance with § 240.13d—1(b)(1)(ii)(J);
           
      (k) ☐

    Group, in accordance with § 240.13d—1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with

    § 240.13d—1(b)(1)(ii)(J), please specify the type of institution:                            

     

    7

     

     

    Item 4. Ownership

     

    (a), (b) and (c)—The information contained on the cover page to this Schedule 13G is incorporated herein by reference.

     

    Item 5. Ownership of Five Percent or Less of a Class
    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following   ☐.
     
    Item 6. Ownership of More than Five Percent on Behalf of Another Person
    Not applicable
     
    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person
    Not applicable
     
    Item 8. Identification and Classification of Members of the Group
    Not applicable
     
    Item 9. Notice of Dissolution of Group
    Not applicable
     
    Item 10. Certification

     By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.

     

    8

     

     

    Signature

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Date: October 4, 2021

     

      Amplitude Healthcare Holdings, LLC
       
      By: Metalmark Amplitude Healthcare Holdings LLC, its managing member
         
       

    By:

    /s/ Kenneth Clifford

        Name: Kenneth Clifford
        Title:   Authorized Person
         
      HC IC Holdings LLC.
       
      By: /s/ Kenneth Clifford
        Name: Kenneth Clifford
        Title:   Member
         
      /s/ Howard Hoffen
      Howard Hoffen
       
      /s/ Kenneth Clifford
      Kenneth Clifford

     

    9

     

     

    Exhibit 99.1 

     

    JOINT FILING AGREEMENT

     

    The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained herein and therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that it knows or has reason to believe that such information is inaccurate.

     

    Dated: October 4, 2021

     

      Amplitude Healthcare Holdings, LLC
       
      By: Metalmark Amplitude Healthcare Holdings
    LLC, its managing member
         
        By: /s/ Kenneth Clifford
       

    Name: 

    Kenneth Clifford

        Title:   Authorized Person

     

      HC IC Holdings LLC.
         
      By: /s/ Kenneth Clifford
        Name:  Kenneth Clifford
        Title: Member

       
      /s/ Howard Hoffen
      Howard Hoffen
       
      /s/ Kenneth Clifford
      Kenneth Clifford

     

     

    10

     

     

    Get the next $AMHC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMHC

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $AMHC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3: New insider Roche Holding Ltd claimed ownership of 4,624,606 units of Voting Common Stock

    3 - Jasper Therapeutics, Inc. (0001788028) (Issuer)

    10/4/21 9:10:43 AM ET
    $AMHC
    Business Services
    Finance

    SEC Form 3: New insider Abingworth Llp claimed ownership of 5,628,558 shares

    3 - Jasper Therapeutics, Inc. (0001788028) (Issuer)

    10/1/21 4:30:52 PM ET
    $AMHC
    Business Services
    Finance

    SEC Form 3: New insider Emster Kurt Von claimed ownership of 5,628,558 shares

    3 - Jasper Therapeutics, Inc. (0001788028) (Issuer)

    10/1/21 4:12:28 PM ET
    $AMHC
    Business Services
    Finance

    $AMHC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Jasper Therapeutics Closes Transaction With Amplitude Healthcare Acquisition Corporation, Creating a Publicly Traded Biotechnology Company Dedicated to Enabling Cures Through Hematopoietic Stem Cell Therapy

    Combined company expected to begin trading on the Nasdaq Global Select Market under "JSPR" and "JSPRW" on or about September 27, 2021 Jasper Therapeutics, Inc., a biotechnology company focused on hematopoietic cell transplant therapies, today announced the completion of its business combination with Amplitude Healthcare Acquisition Corporation (NASDAQ:AMHC), a special purpose acquisition company sponsored by affiliates of Avego Management, LLC and Metalmark Capital. The business combination closed on September 24, 2021. Following the closing, the combined company will operate as Jasper Therapeutics, Inc. and, on or about September 27, 2021, its shares of voting common stock and warrants ar

    9/24/21 4:05:00 PM ET
    $AMHC
    Business Services
    Finance

    Amplitude Healthcare Acquisition Corporation Announces Shareholder Approval of Business Combination with Jasper Therapeutics, Inc.

    Exhibit 99.1 REDWOOD CITY, Calif. and NEW YORK, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Amplitude Healthcare Acquisition Corporation (NASDAQ:AMHC) ("AMHC"), a special purpose acquisition company, today announced that its stockholders voted to approve the previously announced business combination (the "Business Combination") with Jasper Therapeutics, Inc. ("Jasper"), a biotechnology company focused on the development of novel curative therapies based on the biology of the hematopoietic stem cell, and all other proposals presented at AMHC''s special shareholder's meeting held on September 22, 2021. AMHC''s shareholders approved the Business Combination proposal with 74.9% votes in favor of the

    9/22/21 6:38:42 PM ET
    $AMHC
    Business Services
    Finance

    $AMHC
    SEC Filings

    View All

    Amplitude Healthcare Acquisition Corporation filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Amendments to the Registrant’s Code of Ethics, or Waiver of a Provision of the Code of Ethics, Financial Statements and Exhibits (Amendment)

    8-K/A - Amplitude Healthcare Acquisition Corp (0001788028) (Filer)

    9/29/21 4:46:02 PM ET
    $AMHC
    Business Services
    Finance

    Amplitude Healthcare Acquisition Corporation filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits, Leadership Update, Unregistered Sales of Equity Securities, Entry into a Material Definitive Agreement, Changes in Registrant’s Certifying Accountant, Change in Shell Company Status, Regulation FD Disclosure

    8-K - Amplitude Healthcare Acquisition Corp (0001788028) (Filer)

    9/29/21 4:37:11 PM ET
    $AMHC
    Business Services
    Finance

    SEC Form 25-NSE filed by Amplitude Healthcare Acquisition Corporation

    25-NSE - Amplitude Healthcare Acquisition Corp (0001788028) (Subject)

    9/27/21 4:02:27 PM ET
    $AMHC
    Business Services
    Finance

    $AMHC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Amplitude Healthcare Acquisition Corporation

    SC 13G - Jasper Therapeutics, Inc. (0001788028) (Subject)

    10/4/21 4:34:30 PM ET
    $AMHC
    Business Services
    Finance

    SEC Form SC 13D filed by Amplitude Healthcare Acquisition Corporation

    SC 13D - Jasper Therapeutics, Inc. (0001788028) (Subject)

    10/4/21 4:10:31 PM ET
    $AMHC
    Business Services
    Finance

    SEC Form SC 13G filed by Amplitude Healthcare Acquisition Corporation

    SC 13G - Jasper Therapeutics, Inc. (0001788028) (Subject)

    10/4/21 4:02:52 PM ET
    $AMHC
    Business Services
    Finance